Q32 Bio Inc. (QTTB) Net margin 2018–2025
Q32 Bio Inc. (QTTB) net profit margin by fiscal year — reported net income divided by reported revenue.
55.5%FY2025 · since FY2018: -1044.3% → 55.5%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 55.5% | — |
| FY2023 | -4649.0% | -4493.0 pp |
| FY2022 | -156.0% | +125.9 pp |
| FY2021 | -281.9% | +4481.0 pp |
| FY2020 | -4762.9% | +1474.5 pp |
| FY2019 | -6237.5% | -5193.2 pp |
| FY2018 | -1044.3% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More QTTB financial trends
QTTB RevenueQTTB Net incomeQTTB Gross profitQTTB Gross marginQTTB Operating incomeQTTB Operating marginQTTB Operating cash flowQTTB Free cash flowQTTB Capital expendituresQTTB Return on equityQTTB Stock buybacksQTTB Dividends paidQTTB Total assetsQTTB Total liabilitiesQTTB Shareholders’ equityQTTB overview →